Wenning bows out of Bayer with strong 2009 healthcare sales
This article was originally published in Scrip
Executive Summary
Bayer's healthcare sales provided a satisfying end to chairman Werner Wenning's end of tenure at the company, increasing by 4% to €16 billion last year, although total group sales were down by 5% to €31.2 billion.